NCT00305825View on ClinicalTrials.gov

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 30, 2006

Study Completion Date

May 24, 2016

Conditions
Breast Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

letrozole

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

94115-1710

UCSF Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

University of California, San Francisco

OTHER

NCT00305825 - Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter